MISIS University staff, led by Professor Dmitry Shtansky, have developed a new generation of medical bandages for treating complex wounds. The prototype is effective against antibiotic-resistant bacteria, including Staphylococcus aeruginosa, Pseudomonas aeruginosa, Escherichia coli, Enterococci, and the fungus Candida auris.
The new headband is based on a nanofiber membrane whose fibers are hundreds of times finer than a human hair. The material is made of the biodegradable polymer polycaprolactone, reinforced with copper oxide nanoparticles, and additionally treated with the antibiotics neomycin and bacitracin.
In animal tests, the dressing reduced blood loss by 4.6 times compared to conventional dressings. Polycaprolactone was chosen for its biocompatibility, strength, and ability to mimic the extracellular matrix.
In the near future, the team plans to conduct expanded preclinical and clinical trials with its strategic partner, the Russian company KroveStop. The dressing will be used in field medicine and hospitals to treat diabetic ulcers and complex burns.
